The global leukapheresis devices market is expected to showcase significant growth from 2020 to 2028. The market was valued at USD 24.46 million in 2020 and is projected to reach USD 36.54 million by 2028, registering a CAGR of X% during the forecast period. Several factors are contributing to the growth of the market. Firstly, the increasing prevalence of chronic diseases such as cancer and autoimmune disorders is driving the demand for leukapheresis devices. These devices are used in the treatment of these diseases by removing diseased or excess white blood cells from the body. Additionally, the growing adoption of leukapheresis procedures in stem cell research and therapy is further boosting market growth.
Despite the challenges posed by the Covid-19 pandemic, the leukapheresis devices market has shown resilience and is poised for robust post-Covid recovery. The pandemic initially disrupted supply chains and led to a temporary decline in elective procedures, impacting market growth. However, with healthcare systems adapting to the new normal and the increasing focus on research and development in the field of immunology, the market is expected to bounce back stronger post-Covid.
Market sentiments towards leukapheresis devices remain positive, with key players investing in technological advancements to enhance the efficiency and efficacy of these devices. Moreover, the rising healthcare expenditure, especially in developing economies, is creating lucrative opportunities for market expansion. Overall, the global leukapheresis devices market is set to experience steady growth in the coming years, driven by increasing disease burden, expanding applications in medical research, and the focus on precision medicine.
https://www.databridgemarketresearch.com/reports/global-leukapheresis-devices-market
Global Leukapheresis Devices Market
-
Type:
- Apheresis Devices
- Leukapheresis Columns and Cell Separators
- Leukoreduction Filters
-
Application:
- Research Applications
- Therapeutic Applications
-
End User:
- Blood Component Providers and Blood Centres
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Hospitals and Transfusion Centres
-
Country Coverage:
- U.S., Canada, Mexico
- Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe
- Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific
- Brazil, Argentina, Rest of South America
- South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa
The global leukapheresis devices market is witnessing significant growth driven by several key factors. An essential aspect contributing to market expansion is the rising prevalence of chronic diseases like cancer and autoimmune disorders. This has increased the demand for leukapheresis devices, which are utilized in the treatment of these conditions through the removal of diseased or excess white blood cells from the body.
Furthermore, the adoption of leukapheresis procedures in stem cell research and therapy is fueling market growth. With advancements in technology, key players in the market are investing in innovation to improve the efficiency and effectiveness of these devices. This focus on technological enhancements is expected to boost market uptake and drive further growth.
Despite experiencing challenges due to the Covid-19 pandemic, the leukapheresis devices market has displayed resilience and is expected to witness a robust post-Covid recovery. The pandemic initially disrupted supply chains and caused a temporary decline in elective procedures, impacting market growth. However, as healthcare systems adapt to the new normal and research and development in immunology intensify, the market is foreseen to bounce back stronger after the pandemic.
Market sentiment is optimistic towards leukapheresis devices, with a positive outlook on market expansion opportunities due to the increasing healthcare expenditure, especially in developing economies. The global leukapheresis devices market is poised for steady growth in the upcoming years, fueled by the escalating disease burden, expanding applications in medical research, and the emphasis on precision medicine.
Market Players:
- Asahi Kasei Medical Co. Ltd
- Haemonetics Corporation
- TERUMO BCT INC.
- STEMCELL Technologies Inc.
- Fresenius SE & Co. KGaA
- HemaCare
- B. Braun Melsungen AG
- Caltag Medsystems Limited
- AllCells
- StemExpress
- PPA
- Cellero
- Precision for Medicine, Inc.
- The Intelligent Tissue Group Lonza
- BioIVT
- Lmb Technologie GmbH
- Grifols, S.A
- Kaneka Medical Europe N.V.
The global leukapheresis devices market is witnessing a significant upsurge due to various factors contributing to its growth trajectory. One crucial driver is the escalating prevalence of chronic diseases like cancer and autoimmune disorders, which has fueled the demand for leukapheresis devices in treating these conditions by eliminating diseased or excess white blood cells. Additionally, the increasing adoption of leukapheresis procedures in stem cell research and therapy is propelling market expansion.
Key market players are dedicating investments towards technological advancements to enhance the efficiency and effectiveness of leukapheresis devices, indicating a strong commitment to innovation within the industry. This strategic focus on innovation is expected to drive greater adoption of these devices and contribute to sustained market growth.
Despite initial setbacks caused by the Covid-19 pandemic, the leukapheresis devices market has exhibited resilience and is on track for a robust recovery post-pandemic. Although disruptions in supply chains and a temporary decline in elective procedures impacted the market, the ongoing adaptation of healthcare systems to the new normal and the increased focus on immunology research are anticipated to bolster market resilience in the post-Covid era.
Market sentiment surrounding leukapheresis devices remains positive, with promising growth opportunities driven by rising healthcare expenditures, particularly in emerging economies. The global leukapheresis devices market is poised for steady growth in the foreseeable future, underpinned by the mounting disease burden, expanding applications in medical research, and the emphasis on precision medicine.
Browse Trending Reports:
Inflammatory Myopathies Market
Vascular Closure Device Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek